News

Pembroke VCT Launches New Equity Issue with Crucial Updates

Pembroke VCT Launches New Equity Issue with Crucial Updates

Pembroke VCT Announces Important Equity Issue Updates

Pembroke VCT PLC, a leading venture capital trust, has provided significant updates regarding its recent B Ordinary Shares allotment. The company's notice clarifies an important detail about the trading commencement date, which is now expected to begin on the London Stock Exchange.

New Share Trading Start Date

After a careful review, Pembroke VCT has determined that trading for the recently allotted B Ordinary Shares will commence around November 27, amending earlier statements. This change is essential for shareholders and potential investors to note in their financial planning.

B Ordinary Shares Overview

On October 9, 2024, Pembroke VCT successfully issued 1,610,329 B Ordinary Shares through an Offer for Subscription. This initiative has the potential to raise up to £40 million, with an additional £20 million available through an over-allotment option. The priced range for these shares is between 100.81p and 107.81p based on the unaudited net asset value of 102.8p per B Ordinary Share, as reported on June 30, 2024.

Valuation Adjustments

As part of the share issuance process, the valuation of shares was adjusted reflecting a dividend of 2.0p per share, which was recorded on September 6 and disbursed on October 4, 2024. Such adjustments highlight the active management of shareholder value at Pembroke VCT.

Total B Ordinary Shares in Circulation

Following this share allotment, the total volume of B Ordinary Shares has increased to 218,641,514. This number represents both the outstanding shares and the total voting rights for shareholders in Pembroke VCT. Understanding these figures is vital for shareholders, especially for disclosure needs as per the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Compliance and Listing Applications

Pembroke VCT has filed applications for the new shares to be officially listed on the Financial Conduct Authority's Official List, along with a proposal for their trading to commence on the main market of the London Stock Exchange. Following allotment, shareholders can expect CREST accounts to be credited, with physical share certificates dispatched within ten business days.

Conclusion on Equity Issue Updates

This announcement serves as a significant update regarding Pembroke VCT's equity issues, providing clarity and transparency to investors and shareholders alike. As the market evolves, staying informed about such shifts is critical for effective investment decisions.

Frequently Asked Questions

What is Pembroke VCT PLC?

Pembroke VCT PLC is a venture capital trust focused on investing in growing businesses in various sectors, enabling investors to support emerging companies.

What types of shares has Pembroke VCT issued?

Pembroke VCT has issued B Ordinary Shares through an Offer for Subscription as part of its capital-raising efforts.

When will the new shares commence trading?

The new B Ordinary Shares are expected to begin trading on the London Stock Exchange around November 27, 2024.

How many shares are currently in circulation?

After the recent allotment, the total number of B Ordinary Shares in circulation has reached 218,641,514.

What should shareholders expect after the allotment?

Post-allotment, shareholders can anticipate that their CREST accounts will be credited, and share certificates will be mailed within ten business days.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Atkins Takes Helm at IEA's Coal Advisory Board

Updated Category News Views 22

Leadership Shake-up in the Energy World Who would've thought? Randall W. Atkins, Ramaco Resources' top gun, has just bagged a primo gig as the top dog at the International Energy Agency's Coal Industry Advisory Board (CIAB). Named by unanimous vote, he's about to steer this ship through the ever-evolving waters of coal's future. Now, I know some folks roll their eyes at...

Continue Reading
Bakery China's International Buyer Surge: A 50% Boost

Updated Category News Views 35

Look Who's Lining Up for Chinese Pastries Alright, here we go. China's baking scene is pulling in audiences far and wide, as if the whole world suddenly caught a whiff of their freshest, steaming buns. The 11th Bakery China Autumn, recently wrapped up at the Wuhan International Expo Center, saw a 50% rise in international buyers. This stat gives you that warm and cozy...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
SRG DocketWatch: Tracking FCC Docs in Real-Time

Updated Category News Views 5

I'll admit it—sometimes the FCC moves like molasses uphill. But keeping track of what they're up to? That's where the real challenge lies. Summit Ridge Group has tossed a lifeline for anyone who's got skin in the game with their new service, SRG DocketWatch. Why SRG DocketWatch Hits the Mark If you're poking your head into more than a few of those 21,000 FCC...

Continue Reading
Sunrate's Bold Move: New Payment Bond with Netstorming

Updated Category News Views 18

Sunrate Joins Forces with Netstorming When two industry powerhouses shake hands, it's wise to sit up and listen. Sunrate, the global whiz in payment solutions, has linked arms with Netstorming, a tech-savvy pioneer in the travel sector. This ironclad partnership was announced at World Travel Market London 2026. Owners of travel businesses should take note: things are...

Continue Reading
Direct Connection Unveils Enthusiast-Centric Parts at SEMA

Updated Category News Views 69

Pumping Up the Horsepower at SEMA 2026 Las Vegas is buzzing with horsepower this November as Direct Connection, the performance arm of Stellantis, unleashes a fresh wave of factory-backed adrenaline at the 2026 SEMA show. Among all the glitter and roar, this isn't just hype—it's the real deal for Mopar fans. Riding High on Factory-Backed Power For the folks knee-deep in...

Continue Reading
Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 72

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
GNSS Simulator Market: $425M by 2031, Key Insight

Updated Category News Views 81

GNSS Simulator Market: Gadgets Meet Growth A market that's been quietly bubbling away on the back burner is about to boil over: The GNSS Simulator Market, pegged at a neat $424.6 million by 2031. Yeah, it might be niche, but those in the know can't get enough of these satellite-signal replicators. Why GNSS Simulators are Crushing It There's a bunch of reasons why GNSS...

Continue Reading
Neera Tanden's Progressive Vision for 2027 and Beyond

Updated Category News Views 51

Neera Tanden Sets the Stage for 2027 When it comes to politics, everyone’s got their two cents, but Neera Tanden’s unpacking a whole piggy bank of progressive dreams. Set against the backdrop of a freshly reshuffled Congress post-midterms, she’s poised to dish out her roadmap for the future at the National Press Club on November 9. A Gathering of Minds This ain't...

Continue Reading
Wincomm & Portwell Unveil Medical AI Tech at MEDICA 2026

Updated Category News Views 104

MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...

Continue Reading

Top 5 Most Recently Viewed Articles

Castle Biosciences Set to Shine at Upcoming Investor Events

Updated Category News Views 220

Castle Biosciences Highlights Participation in Investor Conferences Castle Biosciences, Inc. (NASDAQ: CSTL), a dedicated company focused on enhancing health through innovative diagnostic tests, has announced its upcoming presentations at two important investor conferences. These events are set to showcase Castle's commitment to advancing patient care with their unique...

Continue Reading
Understanding Aktsiaselts Infortar's Recent Share Buybacks Activity

Updated Category News Views 72

Overview of Aktsiaselts Infortar's Share Acquisition Transactions Aktsiaselts Infortar has engaged in a series of strategic share acquisitions on the Nasdaq Tallinn Stock Exchange over a specified period. These transactions demonstrate the company's commitment to enhancing shareholder value while positioning itself favorably in the market. Detailed Share Acquisition...

Continue Reading
Apollo Scooters Reveal the Truth About Winter Range Loss

Updated Category News Views 113

When the mercury dips, how far can your electric scooter really take you? Apollo Scooters has put some meat on the bones of this question, digging through over half a million rides to bust the myth that chillier days chop your scooter's range by half. Reality Check on Winter Range Loss For years, folks have griped that cold weather slashes electric vehicle range by a...

Continue Reading
Discover the Exciting Hightail: Dust Moto's Electric Revolution

Updated Category News Views 447

Dust Moto Launches the All-Electric Hightail Dirt Bike Dust Moto has paved the way for a new era in dirt biking with the launch of the Hightail, an all-electric dirt bike that aims to elevate the riding experience for enthusiasts everywhere. This innovative bike is engineered for performance with an impressive 42hp and a robust 660Nm of torque, while weighing less than...

Continue Reading
Understanding Your Rights: Actinium Pharmaceuticals and Investor Losses

Updated Category News Views 292

Actinium Pharmaceuticals: An Overview for Investors In the world of pharmaceuticals, it's essential for investors to stay informed about the companies they choose to trust with their investments. Actinium Pharmaceuticals, Inc. (NYSE: ATNM) is currently under scrutiny as a result of alleged securities law violations. If you’ve experienced significant losses exceeding...

Continue Reading